GSK pairs Wynonna Judd album with Alli

Share this article:

Consumers purchasing GlaxoSmithKline's weight loss drug Alli will receive a free copy of Wynonna Judd's new album Sing, beginning in March.

Two hundred thousand copies of the album will be packaged with select 30-day starter packs and 170-count refill packs of the drug, which is FDA approved and available over the counter.

The deal is the latest incarnation of Judd's ongoing partnership with Alli, which includes TV, print ads and a contest offering a trip for two to Nashville for a private concert.

“In celebration of the start of Wynonna's journey on Alli, we are offering her newest and critically acclaimed album, Sing,” said Rachel Ferdinando, VP, marketing, weight control, at GSK, in a statement. “This program further exhibits the brand's commitment to supporting Wynonna in both her personal and professional journeys, while giving something back to our loyal consumers.”

“I hope that I can inspire people to be better…that they can see themselves in me and say, 'If she can do it, I can do it,'" said Judd in the statement.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...